Home / Stocks / AVIR

AVIR insider trading

Atea Pharmaceuticals, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
4
Bought · 24 mo
$214k
Buys · last 90 days
0 · $0
Most recent buy
2026-05-21

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-05-21Murphy Polly A.
Director
Bought6,100$4.17$25k
2026-05-20Murphy Polly A.
Director
Bought6,100$4.17$25k
2025-01-17BERGER FRANKLIN M
Director
Bought25,000$3.26$81k
2025-01-17BERGER FRANKLIN M
Director
Bought25,000$3.26$81k
2024-12-12BERGER FRANKLIN M
Director
Sold359,606$2.85$1.0M

Most active insider buyers

InsiderRoleBuysTotal bought
BERGER FRANKLIN MDirector2$163k
Murphy Polly A.Director2$51k

See AVIR on the chart

Every insider buy and sell for AVIR plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.